Portland, OR – Donatelli signage design team draws up plans for Oncothyreon internal signage installation in advance of grand opening event. Donatelli rendered concepts for both the Oncothyreon lobby and reception area brand signage. Donatelli also defined material specifications and coordinated fabrication and final installation.
Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. Oncothyreon is currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. There business focus includes both synthetic vaccines and small molecules for a variety of cancer indications. Oncothyreon is headquartered in Seattle, Washington. The Company is traded on the NASDAQ National Market under the symbol ONTY.